rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-1-23
|
pubmed:abstractText |
The anticariogenic potential of casein phosphopeptide-amorphous calcium phosphate nanocomplexes (CPP-ACP) has been demonstrated using laboratory, animal and human in situ caries models. The aim of this study was to determine the effect of CPP-ACP incorporation into a sugar-free lozenge (pressed mint tablet) on enamel remineralization in a human in situ model.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
D
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0045-0421
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
240-3
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:14738126-Administration, Buccal,
pubmed-meshheading:14738126-Adult,
pubmed-meshheading:14738126-Analysis of Variance,
pubmed-meshheading:14738126-Calcium Phosphates,
pubmed-meshheading:14738126-Cariostatic Agents,
pubmed-meshheading:14738126-Caseins,
pubmed-meshheading:14738126-Cross-Over Studies,
pubmed-meshheading:14738126-Densitometry,
pubmed-meshheading:14738126-Dental Enamel,
pubmed-meshheading:14738126-Double-Blind Method,
pubmed-meshheading:14738126-Drug Combinations,
pubmed-meshheading:14738126-Female,
pubmed-meshheading:14738126-Humans,
pubmed-meshheading:14738126-Male,
pubmed-meshheading:14738126-Microradiography,
pubmed-meshheading:14738126-Pharmaceutical Vehicles,
pubmed-meshheading:14738126-Sweetening Agents,
pubmed-meshheading:14738126-Tooth Remineralization
|
pubmed:year |
2003
|
pubmed:articleTitle |
Remineralization of enamel subsurface lesions in situ by sugar-free lozenges containing casein phosphopeptide-amorphous calcium phosphate.
|
pubmed:affiliation |
School of Dental Science, The University of Melbourne, Victoria.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|